Skylands Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.15M Hold
209,225
0.63% 48
2026
Q1
$5.01M Sell
209,225
-4,375
-2% -$107K 0.66% 45
2025
Q4
$4.83M Sell
213,600
-81,600
-28% -$1.78M 0.66% 41
2025
Q3
$5.95M Sell
295,200
-138,450
-32% -$2.32M 0.82% 35
2025
Q2
$6.19M Sell
433,650
-116,500
-21% -$1.36M 0.9% 33
2025
Q1
$5.78M Buy
550,150
+45,650
+9% +$516K 0.83% 36
2024
Q4
$6.11M Buy
504,500
+134,150
+36% +$1.76M 0.85% 38
2024
Q3
$5.44M Buy
370,350
+143,250
+63% +$2M 0.74% 47
2024
Q2
$3.28M Sell
227,100
-25,400
-10% -$406K 0.46% 61
2024
Q1
$4.11M Sell
252,500
-101,450
-29% -$1.59M 0.57% 49
2023
Q4
$5.27M Sell
353,950
-63,500
-15% -$719K 0.78% 40
2023
Q3
$4.69M Sell
417,450
-113,837
-21% -$1.32M 0.71% 40
2023
Q2
$5.34M Buy
531,287
+72,287
+16% +$671K 0.77% 36
2023
Q1
$4.31M Buy
459,000
+250,550
+120% +$2.96M 0.63% 42
2022
Q4
$2.55M Buy
208,450
+36,000
+21% +$449K 0.4% 55
2022
Q3
$2.14M Buy
172,450
+134,750
+357% +$2.36M 0.35% 60
2022
Q2
$740K Buy
+37,700
New +$892K 0.11% 96

Other funds holding ELAN

Skylands Capital's ELAN Position: Q2 2026 in Review

Skylands Capital held its Elanco Animal Health (ELAN) position steady in Q2 2026 at 209,225 shares worth $5.15M. The position accounts for 0.63% of the portfolio, ranked #48.

Skylands Capital first reported a position in ELAN in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.19M in Q2 2025. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Skylands Capital held 209,225 shares of Elanco Animal Health worth $5.15M as of Q2 2026.
  • Skylands Capital left its Elanco Animal Health share count unchanged in Q2 2026.
  • Elanco Animal Health made up 0.63% of Skylands Capital's portfolio in Q2 2026, its #48 holding.
  • Skylands Capital first reported a position in Elanco Animal Health in Q2 2022 and has held it in 17 quarters since.
  • Skylands Capital's Elanco Animal Health position peaked at $6.19M in Q2 2025.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Skylands Capital's 13F filing for Q2 2026, filed 24 Jul 2026.